30 Turbo Cancer Treatment race is on: Johnson & Johnson just completed $2 billion cancer drug buy of Ambrx on March 7, 2024 - Merck, Novartis, Sanofi, Eli Lilly, AbbVie, Pfizer, BMS - they all want in! (twitter.com) posted 259 days ago by brain_dead 259 days ago by brain_dead +30 / -0 10 comments share 10 comments share save hide report block hide replies
and now they collect profits on treatment of the cancer caused by the jabs (which they also profited from) they mandated. Double win for evil.
Yes. I have friends and family who took that shit. One of them is now turbo cancer of the epithelial. So damn sad.
What can and should happen here is mass promulgation of alternative cures KNOWN by we anons and let the pharma killers die on the vine. Now if Med Beds are availible, game changer too.
lol, yep